Regional anesthesia and pain medicine
-
Reg Anesth Pain Med · May 2023
Clinical TrialResidual anti-Xa activity in plasma of patients presenting for electively planned neuraxial regional anesthesia.
To determine the incidence of increased anti-Xa activity within plasma levels 24 hours after administration of therapeutic dose low-molecular-weight heparin in patients presenting for elective neuraxial anesthesia. ⋯ Relevant residual anticoagulant activity, as measured by plasma anti-Xa levels within a prophylactic range, is measurable 24 hours after the last administration of therapeutic dose low-molecular-weight heparin.
-
Reg Anesth Pain Med · May 2023
Association of patient characteristics with the receipt of regional anesthesia.
Regional anesthesia (RA) may improve patient-related outcomes, including decreased operative complications, shortened recovery times, and lower hospital readmission rates. More analyses are needed using a diverse set of databases to examine characteristics associated with the receipt of RA. ⋯ RA use varies with respect to race, insurance status, and type of surgery.